Target Audience and Goal Statement
This activity is intended for dermatologists, facial plastic surgeons, ophthalmic plastic surgeons, and other physicians and
nurses involved in aesthetic treatments.
The goal of this activity is to review the principles of minimally invasive facial rejuvenation.
Upon completion of this activity, participants will be able to:
- Elucidate the new paradigm of facial aging
- Review the neuromodulators approved for aesthetic use in the United States and describe their similarities and differences
- Describe the principles of safe, effective minimally invasive facial rejuvenation, with an emphasis on neuromodulators
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Authors
-
Marc S. Cohen, MD
Assistant Professor, Department of Ophthalmology, Jefferson Medical College; Associate Surgeon, Wills Eye Institute, Philadelphia,
Pennsylvania; Ophthalmic Plastic Surgeon, Bala Cynwyd, Pennsylvania
Disclosures
Disclosure: Marc S. Cohen, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan, Inc.
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Medicis Pharmaceutical Corporation
Dr. Cohen does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Cohen does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
-
Thomas E. Rohrer, MD
Clinical Associate Professor of Dermatology, Boston University School of Medicine, Massachusetts; Clinical Associate Professor,
Department of Dermatology, Brown University, Providence, Rhode Island; Dermatologist, SkinCare Physicians, Chestnut Hill,
Massachusetts
Disclosures
Disclosure: Thomas E. Rohrer, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Candela Corporation; Cynosure, Inc.; Julia Therapeutics; Medicis Pharmaceutical Corporation
Served as a speaker or a member of a speakers bureau for: Candela Corporation; Medicis Pharmaceutical Corporation; Allergan,
Inc.; Lumenis
Received grants for clinical research from: Allergan, Inc.; Candela Corporation; Radiancy
Owns stock, stock options or bonds from: Julia Therapeutics, Radiancy
Dr. Rohrer does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Rohrer does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
-
Steven H. Dayan, MD
Clinical Assistant Professor, Department of Otolaryngology, University of Illinois at Chicago; Owner and Plastic Surgeon,
Chicago Center for Facial Plastic Surgery, Chicago, Illinois
Disclosures
Disclosure: Steven H. Dayan, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Walgreen’s Health Initiative
Served as a speaker or a member of a speakers bureau for: Lumenis
Received grants for clinical research from: Ellman International, Inc.; Cynosure, Inc.; Allergan, Inc.; Medicis Pharmaceutical
Corporation; Biopelle; Bioform; Merz Pharmaceuticals; Oxygen Biotherapeutics; Mentor Corporation; Forest Pharmaceuticals;
AstraZeneca Pharmaceuticals LP; ViThera Laboratories, LLC; Colbar Lifescience, Ltd.
Dr. Dayan does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr. Dayan does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editor
CME Reviewer
Nurse Planner
-
Laurie E. Scudder, DNP, NP
Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing
and Allied Health, George Washington University, Washington, DC
Disclosures
Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.75
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For Nurses
-
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission
on Accreditation.
Awarded 0.75 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future
programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
